The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers

This publication has 21 references indexed in Scilit:

• Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2003
• Cardiovascular System Effects of Marijuana
  The Journal of Clinical Pharmacology, 2002
• Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
  Gastroenterology, 2002
• Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
  Journal of the American College of Cardiology, 2001
• Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2001
• Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
  Nature Medicine, 2001
• Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB ₁ Receptor Knockout Mice
  Science, 1999
• Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension
  The FASEB Journal, 1998
• Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
  Nature, 1997
• The effects of combinations of intranasal cocaine, smoked marijuana, and task performance on heart rate and blood pressure
  Pharmacology Biochemistry and Behavior, 1990